首页|某院替加环素的应用情况及合理性分析

某院替加环素的应用情况及合理性分析

扫码查看
目的 分析替加环素在云浮市人民医院的应用情况及合理性。方法 选取云浮市人民医院 2022 年~2023 年使用替加环素治疗的 92 份患者用药信息为研究对象,分析替加环素在院内的科室分布及使用情况、不合理用药发生情况、联合用药及用药目的、不良反应发生情况。结果 92 例使用替加环素治疗的患者主要来源于呼吸科(36。96%)、重症医学科(28。26%)、神经内科(8。70%);标本送检率79。35%;疗程<5 d 41 例;疗程 5~14 d 41 例,治疗有效者 30 例;疗程>14 d 10 例,治疗有效者 6 例;存在不合理用药现象 33 次,总发生率 35。87%;超说明书用药 19 次,发生率 20。65%;单药治疗 19 例,占比 20。65%;二联用药共 68 例,占比 73。91%;三联用药 15 例,占比16。30%;13 例发生不良反应,占比 14。13%。结论 云浮市人民医院替加环素使用存在一定的不合理现象,后续可通过会诊、加强管理等方法方法防止替加环素滥用并提高其合理用药率。
Application and rationality analysis of tigacycline in hospital
Objective To analyze the application and rationality of tigacycline in Yunfu People's Hospital.Methods 92 patients treated with tigacycline in Yunfu People's Hospital from 2022 to 2023 were selected as the study objects,and the distribution and use of tigacycline in the hospital departments,the occurrence of irrational drug use,the combination of drug use and the purpose of drug use,and the occurrence of adverse reactions were analyzed.Results The 92 patients treated with tigacycline were mainly from respiratory department(36.96%),intensive care department(28.26%)and neurology department(8.70%).The detection rate of specimens was 79.35%;The treatment course was less than 5 days in 41 cases;The treatment course was 5~14 days in 41 cases,and 30 cases were effective.The treatment course was longer than 14 days in 10 cases,and 6 cases were effective.There were 33 irrational drug use,the total incidence was 35.87%;Off-label drug use occurred 19 times,with an incidence of 20.65%.19 cases(20.65%)were treated with monotherapy.A total of 68 cases(73.91%)were treated with two drugs.Triple drug was used in 15 cases,accounting for 16.30%;Adverse reactions occurred in 13 cases(14.13%).Conclusion The use of tigecycline in Yunfu People's Hospital is unreasonable.The abuse of tigecycline can be prevented and the rational use rate can be improved through consultation and management.

TigacyclineIrrational drug useDrug combination

陈燕平、陈少环

展开 >

云浮市人民医院药学部,广东 云浮 527300

替加环素 不合理用药 联合用药

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(12)